{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T21:31:43Z","timestamp":1792445503408,"version":"4.5.0"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2023,4,15]],"date-time":"2023-04-15T00:00:00Z","timestamp":1681516800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,4,15]],"date-time":"2023-04-15T00:00:00Z","timestamp":1681516800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["P50CA058223"],"award-info":[{"award-number":["P50CA058223"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100008615","name":"Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill","doi-asserted-by":"publisher","award":["P30 CA016086"],"award-info":[{"award-number":["P30 CA016086"]}],"id":[{"id":"10.13039\/100008615","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1007\/s10549-023-06937-9","type":"journal-article","created":{"date-parts":[[2023,4,15]],"date-time":"2023-04-15T17:02:21Z","timestamp":1681578141000},"page":"589-601","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["High expression of the RET receptor tyrosine kinase and its ligand GDNF identifies a high-risk subset of estrogen receptor positive breast cancer"],"prefix":"10.1007","volume":"199","author":[{"given":"Rasha T.","family":"Kakati","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyunsoo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Austin","family":"Whitman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8644-0178","authenticated-orcid":false,"given":"Philip M.","family":"Spanheimer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,4,15]]},"reference":[{"issue":"8","key":"6937_CR1","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.3390\/ijms17081357","volume":"17","author":"M Rond\u00f3n-Lagos","year":"2016","unstructured":"Rond\u00f3n-Lagos M, Villegas V, Rangel N, S\u00e1nchez M, Zaphiropoulos P (2016) Tamoxifen resistance: emerging molecular targets. IJMS 17(8):1357","journal-title":"IJMS"},{"issue":"11","key":"6937_CR2","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1002\/cac2.12207","volume":"41","author":"S Lei","year":"2021","unstructured":"Lei S, Zheng R, Zhang S, Wang S, Chen R, Sun K, Zeng H, Zhou J, Wei W (2021) Global patterns of breast cancer incidence and mortality: a population-based cancer registry data analysis from 2000 to 2020. Cancer Commun (Lond) 41(11):1183\u20131194","journal-title":"Cancer Commun (Lond)"},{"issue":"19","key":"6937_CR3","doi-asserted-by":"crossref","first-page":"10869","DOI":"10.1073\/pnas.191367098","volume":"98","author":"T S\u00f8rlie","year":"2001","unstructured":"S\u00f8rlie T, Perou CM, Tibshirani R, Aas T, Geisler S, Johnsen H, Hastie T, Eisen MB, van de Rijn M, Jeffrey SS, Thorsen T, Quist H, Matese JC, Brown PO, Botstein D, L\u00f8nning PE, B\u00f8rresen-Dale AL (2001) Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci USA 98(19):10869\u201310874","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"6937_CR4","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.ccell.2020.03.009","volume":"37","author":"AB Hanker","year":"2020","unstructured":"Hanker AB, Sudhan DR, Arteaga CL (2020) Overcoming endocrine resistance in breast cancer. Cancer Cell 37(4):496\u2013513","journal-title":"Cancer Cell"},{"key":"6937_CR5","doi-asserted-by":"crossref","first-page":"153303381989633","DOI":"10.1177\/1533033819896331","volume":"19","author":"X-r Liu","year":"2020","unstructured":"Liu X-r, Zhang R-y, Gong H, Rugo HS, Chen L-b, Yuan F, Che J-w, Tie J, Shao B, Wan F-l, Kong W-y, Song G-h, Jiang H-f, Guo-bing X, Li H-p (2020) Methylome variation predicts exemestane resistance in advanced ER + breast cancer. Technol Cancer Res Treat 19:153303381989633","journal-title":"Technol Cancer Res Treat"},{"issue":"3","key":"6937_CR6","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.ccell.2018.08.008","volume":"34","author":"P Razavi","year":"2018","unstructured":"Razavi P, Chang MT, Xu G, Bandlamudi C, Ross DS, Vasan N, Cai Y, Bielski CM, Donoghue MTA, Jonsson P, Penson A, Shen R, Pareja F, Kundra R, Middha S, Cheng ML, Zehir A, Kandoth C, Patel R, Huberman K, Smyth LM, Jhaveri K, Modi S, Traina TA, Dang C, Zhang W, Weigelt B, Li BT, Ladanyi M, Hyman DM, Schultz N, Robson ME, Hudis C, Brogi E, Viale A, Norton L, Dickler MN, Berger MF, Iacobuzio-Donahue CA, Chandarlapaty S, Scaltriti M, Reis-Filho JS, Solit DB, Taylor BS, Baselga J (2018) The genomic landscape of endocrine-resistant advanced breast cancers. Cancer Cell 34(3):427-438.e6","journal-title":"Cancer Cell"},{"issue":"16","key":"6937_CR7","doi-asserted-by":"crossref","first-page":"3618","DOI":"10.1158\/1078-0432.CCR-21-3189","volume":"28","author":"Y Xia","year":"2022","unstructured":"Xia Y, He X, Renshaw L, Martinez-Perez C, Kay C, Gray M, Meehan J, Parker JS, Perou CM, Carey LA, Dixon JM, Turnbull A (2022) Integrated DNA and RNA sequencing reveals drivers of endocrine resistance in estrogen receptor-positive breast cancer. Clin Cancer Res 28(16):3618\u20133629","journal-title":"Clin Cancer Res"},{"issue":"33","key":"6937_CR8","doi-asserted-by":"crossref","first-page":"4648","DOI":"10.1038\/onc.2010.209","volume":"29","author":"I Plaza-Menacho","year":"2010","unstructured":"Plaza-Menacho I, Morandi A, Robertson D, Pancholi S, Drury S, Dowsett M, Martin LA, Isacke CM (2010) Targeting the receptor tyrosine kinase RET sensitizes breast cancer cells to tamoxifen treatment and reveals a role for RET in endocrine resistance. Oncogene 29(33):4648\u20134657","journal-title":"Oncogene"},{"issue":"4","key":"6937_CR9","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1097\/SLA.0b013e3182a6f552","volume":"259","author":"PM Spanheimer","year":"2014","unstructured":"Spanheimer PM, Cyr AR, Gillum MP, Woodfield GW, Askeland RW, Weigel RJ (2014) Distinct pathways regulated by RET and estrogen receptor in luminal breast cancer demonstrate the biological basis for combination therapy. Ann Surg 259(4):793\u2013799","journal-title":"Ann Surg"},{"issue":"8","key":"6937_CR10","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1158\/1078-0432.CCR-13-2221","volume":"20","author":"PM Spanheimer","year":"2014","unstructured":"Spanheimer PM, Park JM, Askeland RW, Kulak MV, Woodfield GW, De Andrade JP, Cyr AR, Sugg SL, Thomas A, Weigel RJ (2014) Inhibition of ret increases the efficacy of antiestrogen and is a novel treatment strategy for luminal breast cancer. Clin Cancer Res 20(8):2115\u20132125","journal-title":"Clin Cancer Res"},{"issue":"5","key":"6937_CR11","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","volume":"2","author":"E Cerami","year":"2012","unstructured":"Cerami E, Gao J, Dogrusoz U, Gross BE, Sumer SO, Aksoy BA, Jacobsen A, Byrne CJ, Heuer ML, Larsson E, Antipin Y, Reva B, Goldberg AP, Sander C, Schultz N (2012) The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov 2(5):401\u2013404","journal-title":"Cancer Discov"},{"key":"6937_CR12","doi-asserted-by":"publisher","unstructured":"Gao J, Aksoy BA, Dogrusoz U, Dresdner G, Gross B, Sumer SO, Sun Y, Jacobsen A, Sinha R, Larsson E, Cerami E, Sander C, Schultz N. Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal. Sci Signal [Internet]. 2013 Apr 2 [cited 2022 Oct 22];6 (269). Available from: https:\/\/www.science.org\/doi\/https:\/\/doi.org\/10.1126\/scisignal.2004088","DOI":"10.1126\/scisignal.2004088"},{"issue":"1","key":"6937_CR13","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s13058-015-0520-4","volume":"17","author":"X Zhao","year":"2015","unstructured":"Zhao X, R\u00f8dland EA, Tibshirani R, Plevritis S (2015) Molecular subtyping for clinically defined breast cancer subgroups. Breast Cancer Res 17(1):29","journal-title":"Breast Cancer Res"},{"key":"6937_CR14","unstructured":"GDNF Protein Expression Summary [Internet]. The Human Protein Atlas. Available from: https:\/\/www.proteinatlas.org\/ENSG00000168621-GDNF"},{"key":"6937_CR15","unstructured":"GDNF [Internet]. NCBI Gene Testing Registry. Available from: https:\/\/www.ncbi.nlm.nih.gov\/gtr\/genes\/2668\/"},{"key":"6937_CR16","unstructured":"Therneau T. A Package for Survival Analysis in R [Internet] [Internet]. 2020. Available from: https:\/\/CRAN.R-project.org\/package=survival"},{"key":"6937_CR17","unstructured":"survminer: Survival Analysis and Visualization [Internet]. Available from: https:\/\/rpkgs.datanovia.com\/survminer\/index.html"},{"issue":"12","key":"6937_CR18","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love MI, Huber W, Anders S (2014) Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol 15(12):550","journal-title":"Genome Biol"},{"issue":"18","key":"6937_CR19","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.1093\/bioinformatics\/btw313","volume":"32","author":"Z Gu","year":"2016","unstructured":"Gu Z, Eils R, Schlesner M (2016) Complex heatmaps reveal patterns and correlations in multidimensional genomic data. Bioinformatics 32(18):2847\u20132849","journal-title":"Bioinformatics"},{"issue":"3","key":"6937_CR20","doi-asserted-by":"crossref","first-page":"100141","DOI":"10.1016\/j.xinn.2021.100141","volume":"2","author":"T Wu","year":"2021","unstructured":"Wu T, Hu E, Xu S, Chen M, Guo P, Dai Z, Feng T, Zhou L, Tang W, Zhan L, Fu X, Liu S, Bo X, Yu G (2021) clusterProfiler 4.0: A universal enrichment tool for interpreting omics data. The Innovation 2(3):100141","journal-title":"The Innovation"},{"issue":"43","key":"6937_CR21","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub TR, Lander ES, Mesirov JP (2005) Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA 102(43):15545\u201315550","journal-title":"Proc Natl Acad Sci USA"},{"key":"6937_CR22","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-319-24277-4","volume-title":"ggplot2: elegant graphics for data analysis","author":"H Wickham","year":"2016","unstructured":"Wickham H (2016) ggplot2: elegant graphics for data analysis, 2nd edn. Springer International Publishing, Cham","edition":"2"},{"issue":"11","key":"6937_CR23","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1101\/gr.1239303","volume":"13","author":"P Shannon","year":"2003","unstructured":"Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, Amin N, Schwikowski B, Ideker T (2003) Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res 13(11):2498\u20132504","journal-title":"Genome Res"},{"key":"6937_CR24","doi-asserted-by":"crossref","first-page":"gkv711","DOI":"10.1093\/nar\/gkv711","volume":"16","author":"S Tarazona","year":"2015","unstructured":"Tarazona S, Furi\u00f3-Tar\u00ed P, Turr\u00e0 D, Pietro AD, Nueda MJ, Ferrer A, Conesa A (2015) Data quality aware analysis of differential expression in RNA-seq with NOISeq R\/Bioc package. Nucleic Acids Res 16:gkv711","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"6937_CR25","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1186\/s12859-018-2435-4","volume":"19","author":"M Foroutan","year":"2018","unstructured":"Foroutan M, Bhuva DD, Lyu R, Horan K, Cursons J, Davis MJ (2018) Single sample scoring of molecular phenotypes. BMC Bioinform 19(1):404","journal-title":"BMC Bioinform"},{"issue":"9","key":"6937_CR26","doi-asserted-by":"crossref","first-page":"499","DOI":"10.3389\/fgene.2018.00499","volume":"24","author":"NS Clayton","year":"2018","unstructured":"Clayton NS, Grose RP (2018) Emerging roles of fibroblast growth factor 10 in cancer. Front Genet 24(9):499","journal-title":"Front Genet"},{"issue":"10","key":"6937_CR27","doi-asserted-by":"crossref","first-page":"839986","DOI":"10.3389\/fcell.2022.839986","volume":"17","author":"Y Zou","year":"2022","unstructured":"Zou Y, Xie J, Tian W, Wu L, Xie Y, Huang S, Tang Y, Deng X, Wu H, Xie X (2022) Integrative analysis of KCNK genes and establishment of a specific prognostic signature for breast cancer. Front Cell Dev Biol 17(10):839986","journal-title":"Front Cell Dev Biol"},{"issue":"8","key":"6937_CR28","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1210\/me.2011-0045","volume":"25","author":"CP Alvarez-Baron","year":"2011","unstructured":"Alvarez-Baron CP, Jonsson P, Thomas C, Dryer SE, Williams C (2011) The two-pore domain potassium channel KCNK5: induction by estrogen receptor \u03b1 and role in proliferation of breast cancer cells. Mol Endocrinol 25(8):1326\u20131336","journal-title":"Mol Endocrinol"},{"issue":"1","key":"6937_CR29","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s10911-022-09516-8","volume":"27","author":"M Valla","year":"2022","unstructured":"Valla M, Kl\u00e6stad E, Ytterhus B, Bofin AM (2022) CCND1 Amplification in breast cancer -associations with proliferation, histopathological grade, molecular subtype and prognosis. J Mammary Gland Biol Neoplasia 27(1):67\u201377","journal-title":"J Mammary Gland Biol Neoplasia"},{"issue":"2","key":"6937_CR30","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s10549-018-4989-2","volume":"173","author":"A Astashchanka","year":"2019","unstructured":"Astashchanka A, Shroka TM, Jacobsen BM (2019) Mucin 2 (MUC2) modulates the aggressiveness of breast cancer. Breast Cancer Res Treat 173(2):289\u2013299","journal-title":"Breast Cancer Res Treat"},{"issue":"12","key":"6937_CR31","doi-asserted-by":"crossref","first-page":"5246","DOI":"10.21037\/tcr-21-1276","volume":"10","author":"X Wang","year":"2021","unstructured":"Wang X, Wang S (2021) Identification of key genes involved in tamoxifen-resistant breast cancer using bioinformatics analysis. Transl Cancer Res TCR 10(12):5246\u20135257","journal-title":"Transl Cancer Res TCR"},{"issue":"7","key":"6937_CR32","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1038\/onc.2011.297","volume":"31","author":"I Lakshmanan","year":"2012","unstructured":"Lakshmanan I, Ponnusamy MP, Das S, Chakraborty S, Haridas D, Mukhopadhyay P, Lele SM, Batra SK (2012) MUC16 induced rapid G2\/M transition via interactions with JAK2 for increased proliferation and anti-apoptosis in breast cancer cells. Oncogene 31(7):805\u2013817","journal-title":"Oncogene"},{"issue":"9","key":"6937_CR33","doi-asserted-by":"crossref","first-page":"798221","DOI":"10.3389\/fcell.2021.798221","volume":"11","author":"J Liu","year":"2022","unstructured":"Liu J, Wang X, Sun J, Chen Y, Li J, Huang J, Du H, Gan L, Qiu Z, Li H, Ren G, Wei Y (2022) The novel methylation biomarker npy5r sensitizes breast cancer cells to chemotherapy. Front Cell Dev Biol 11(9):798221","journal-title":"Front Cell Dev Biol"},{"issue":"4","key":"6937_CR34","doi-asserted-by":"crossref","first-page":"524","DOI":"10.4103\/0019-509X.175343","volume":"51","author":"X Zheng","year":"2014","unstructured":"Zheng X, Zhang Y, Qi X, Wang M, Sun P, Zhang Y, Jiang J (2014) Role of Sphk1 in the malignant transformation of breast epithelial cells and breast cancer progression. Indian J Cancer 51(4):524","journal-title":"Indian J Cancer"},{"issue":"3","key":"6937_CR35","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/ng1180","volume":"34","author":"VK Mootha","year":"2003","unstructured":"Mootha VK, Lindgren CM, Eriksson KF, Subramanian A, Sihag S, Lehar J, Puigserver P, Carlsson E, Ridderstr\u00e5le M, Laurila E, Houstis N, Daly MJ, Patterson N, Mesirov JP, Golub TR, Tamayo P, Spiegelman B, Lander ES, Hirschhorn JN, Altshuler D, Groop LC (2003) PGC-1\u03b1-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet 34(3):267\u2013273","journal-title":"Nat Genet"},{"issue":"1","key":"6937_CR36","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1002\/cam4.990","volume":"6","author":"J Wang","year":"2017","unstructured":"Wang J, Xu Y, Li L, Wang L, Yao R, Sun Q, Du G (2017) FOXC1 is associated with estrogen receptor alpha and affects sensitivity of tamoxifen treatment in breast cancer. Cancer Med 6(1):275\u2013287","journal-title":"Cancer Med"},{"issue":"10","key":"6937_CR37","doi-asserted-by":"crossref","first-page":"2766","DOI":"10.1158\/1055-9965.EPI-07-2891","volume":"17","author":"MM Gaudet","year":"2008","unstructured":"Gaudet MM, Chanock S, Dunning A, Driver K, Brinton LA, Lissowska J, Peplonska B, Pharoah P, Garcia-Closas M (2008) HSD17B1 genetic variants and hormone receptor-defined breast cancer. Cancer Epidemiol Biomark Prev 17(10):2766\u20132772","journal-title":"Cancer Epidemiol Biomark Prev"},{"issue":"33","key":"6937_CR38","doi-asserted-by":"crossref","first-page":"e26896","DOI":"10.1097\/MD.0000000000026896","volume":"100","author":"TY Jin","year":"2021","unstructured":"Jin TY, Saindane M, Park KS, Kim S, Nam S, Yoo Y, Yang JH, Yun I (2021) LEP as a potential biomarker in prognosis of breast cancer: systemic review and meta analyses (PRISMA). Medicine 100(33):e26896","journal-title":"Medicine"},{"issue":"2","key":"6937_CR39","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.ajpath.2011.10.020","volume":"180","author":"J Liu","year":"2012","unstructured":"Liu J, Welm B, Boucher KM, Ebbert MTW, Bernard PS (2012) TRIM29 functions as a tumor suppressor in nontumorigenic breast cells and invasive ER+ breast cancer. Am J Pathol 180(2):839\u2013847","journal-title":"Am J Pathol"},{"issue":"1","key":"6937_CR40","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s13058-022-01502-6","volume":"24","author":"L Yin","year":"2022","unstructured":"Yin L, Li Q, Mrdenovic S, Chu GCY, Wu BJ, Bu H, Duan P, Kim J, You S, Lewis MS, Liang G, Wang R, Zhau HE, Chung LWK (2022) KRT13 promotes stemness and drives metastasis in breast cancer through a plakoglobin\/c-Myc signaling pathway. Breast Cancer Res 24(1):7","journal-title":"Breast Cancer Res"},{"key":"6937_CR41","unstructured":"National Library of Medicine Gene Database [Internet]. Available from: https:\/\/www.ncbi.nlm.nih.gov\/gene\/?term="},{"key":"6937_CR42","doi-asserted-by":"crossref","first-page":"100676","DOI":"10.1016\/j.jbc.2021.100676","volume":"296","author":"X Guo","year":"2021","unstructured":"Guo X, Ramirez I, Garcia YA, Velasquez EF, Gholkar AA, Cohn W, Whitelegge JP, Tofig B, Damoiseaux R, Torres JZ (2021) DUSP7 regulates the activity of ERK2 to promote proper chromosome alignment during cell division. J Biol Chem 296:100676","journal-title":"J Biol Chem"},{"issue":"4","key":"6937_CR43","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1158\/1541-7786.MCR-21-0658","volume":"20","author":"L Li","year":"2022","unstructured":"Li L, Wang N, Xiong Y, Guo G, Zhu M, Gu Y (2022) Transcription factor FOSL1 enhances drug resistance of breast cancer through DUSP7-mediated dephosphorylation of PEA15. Mol Cancer Res 20(4):515\u2013526","journal-title":"Mol Cancer Res"},{"issue":"1","key":"6937_CR44","doi-asserted-by":"crossref","first-page":"5248","DOI":"10.1038\/s41467-021-25523-5","volume":"12","author":"H Adhikari","year":"2021","unstructured":"Adhikari H, Kattan WE, Kumar S, Zhou P, Hancock JF, Counter CM (2021) Oncogenic KRAS is dependent upon an EFR3A-PI4KA signaling axis for potent tumorigenic activity. Nat Commun 12(1):5248","journal-title":"Nat Commun"},{"issue":"2019","key":"6937_CR45","first-page":"1","volume":"15","author":"H Liu","year":"2019","unstructured":"Liu H, Wen T, Zhou Y, Fan X, Du T, Gao T, Li L, Liu J, Yang L, Yao J, Ge Y, An G (2019) DCLK1 plays a metastatic-promoting role in human breast cancer cells. Biomed Res Int 15(2019):1\u20138","journal-title":"Biomed Res Int"},{"issue":"2","key":"6937_CR46","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s10911-008-9079-3","volume":"13","author":"M Sundvall","year":"2008","unstructured":"Sundvall M, Iljin K, Kilpinen S, Sara H, Kallioniemi OP, Elenius K (2008) Role of ErbB4 in breast cancer. J Mammary Gland Biol Neoplasia 13(2):259\u2013268","journal-title":"J Mammary Gland Biol Neoplasia"},{"issue":"1","key":"6937_CR47","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1080\/14756366.2020.1843452","volume":"36","author":"MW Chao","year":"2021","unstructured":"Chao MW, Lin TE, HuangFu WC, Chang CD, Tu HJ, Chen LC, Yen SC, Sung TY, Huang WJ, Yang CR, Pan SL, Hsu KC (2021) Identification of a dual TAOK1 and MAP4K5 inhibitor using a structure-based virtual screening approach. J Enzyme Inhib Med Chem 36(1):98\u2013108","journal-title":"J Enzyme Inhib Med Chem"},{"issue":"3","key":"6937_CR48","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s10549-005-9011-0","volume":"95","author":"HW Lo","year":"2006","unstructured":"Lo HW, Hsu SC, Hung MC (2006) EGFR signaling pathway in breast cancers: from traditional signal transduction to direct nuclear translocalization. Breast Cancer Res Treat 95(3):211\u2013218","journal-title":"Breast Cancer Res Treat"},{"issue":"11","key":"6937_CR49","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1038\/s41419-020-03203-4","volume":"11","author":"D Bose","year":"2020","unstructured":"Bose D, Banerjee S, Singh RK, Wise LM, Robertson ES (2020) Vascular endothelial growth factor encoded by Parapoxviruses can regulate metabolism and survival of triple negative breast cancer cells. Cell Death Dis 11(11):996","journal-title":"Cell Death Dis"},{"key":"6937_CR50","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2147\/CMAR.S182521","volume":"11","author":"C Gao","year":"2018","unstructured":"Gao C, Li H, Zhuang J, Zhang H, Wang K, Yang J, Liu C, Liu L, Zhou C, Sun C (2018) The construction and analysis of ceRNA networks in invasive breast cancer: a study based on The Cancer Genome Atlas. CMAR 11:1\u201311","journal-title":"CMAR"},{"issue":"8","key":"6937_CR51","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1056\/NEJMoa1714448","volume":"378","author":"A Drilon","year":"2018","unstructured":"Drilon A, Laetsch TW, Kummar S, DuBois SG, Lassen UN, Demetri GD, Nathenson M, Doebele RC, Farago AF, Pappo AS, Turpin B, Dowlati A, Brose MS, Mascarenhas L, Federman N, Berlin J, El-Deiry WS, Baik C, Deeken J, Boni V, Nagasubramanian R, Taylor M, Rudzinski ER, Meric-Bernstam F, Sohal DPS, Ma PC, Raez LE, Hechtman JF, Benayed R, Ladanyi M, Tuch BB, Ebata K, Cruickshank S, Ku NC, Cox MC, Hawkins DS, Hong DS, Hyman DM (2018) Efficacy of Larotrectinib in TRK fusion-positive cancers in adults and children. N Engl J Med 378(8):731\u2013739","journal-title":"N Engl J Med"},{"issue":"24","key":"6937_CR52","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1182\/blood.2019003691","volume":"135","author":"SK Joshi","year":"2020","unstructured":"Joshi SK, Qian K, Bisson WH, Watanabe-Smith K, Huang A, Bottomly D, Traer E, Tyner JW, McWeeney SK, Davare MA, Druker BJ, Tognon CE (2020) Discovery and characterization of targetable NTRK point mutations in hematologic neoplasms. Blood 135(24):2159\u20132170","journal-title":"Blood"},{"issue":"11","key":"6937_CR53","doi-asserted-by":"crossref","first-page":"0242141","DOI":"10.1371\/journal.pone.0242141","volume":"15","author":"A Bera","year":"2020","unstructured":"Bera A, Subramanian M, Karaian J, Eklund M, Radhakrishnan S, Gana N, Rothwell S, Pollard H, Hu H, Shriver CD, Srivastava M (2020) Functional role of vitronectin in breast cancer. Ramos JW, editor. PLoS ONE 15(11):0242141","journal-title":"PLoS ONE"},{"issue":"17","key":"6937_CR54","doi-asserted-by":"crossref","first-page":"13615","DOI":"10.1074\/jbc.M008384200","volume":"276","author":"M Jakacka","year":"2001","unstructured":"Jakacka M, Ito M, Weiss J, Chien PY, Gehm BD, Jameson JL (2001) Estrogen receptor binding to DNA is not required for its activity through the nonclassical AP1 pathway. J Biol Chem 276(17):13615\u201313621","journal-title":"J Biol Chem"},{"issue":"6","key":"6937_CR55","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1210\/me.2003-0441","volume":"18","author":"V Bourdeau","year":"2004","unstructured":"Bourdeau V, Desch\u00eanes J, M\u00e9tivier R, Nagai Y, Nguyen D, Bretschneider N, Gannon F, White JH, Mader S (2004) Genome-wide identification of high-affinity estrogen response elements in human and mouse. Mol Endocrinol 18(6):1411\u20131427","journal-title":"Mol Endocrinol"},{"issue":"1","key":"6937_CR56","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1186\/1471-2407-14-871","volume":"14","author":"RM Hallett","year":"2014","unstructured":"Hallett RM, Hassell JA (2014) Estrogen independent gene expression defines clinically relevant subgroups of estrogen receptor positive breast cancer. BMC Cancer 14(1):871","journal-title":"BMC Cancer"},{"issue":"7","key":"6937_CR57","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1245\/s10434-012-2570-5","volume":"20","author":"PM Spanheimer","year":"2013","unstructured":"Spanheimer PM, Woodfield GW, Cyr AR, Kulak MV, White-Baer LS, Bair TB, Weigel RJ (2013) Expression of the RET Proto-oncogene is regulated by TFAP2C in breast cancer independent of the estrogen receptor. Ann Surg Oncol 20(7):2204\u20132212","journal-title":"Ann Surg Oncol"},{"issue":"9","key":"6937_CR58","doi-asserted-by":"crossref","first-page":"3369","DOI":"10.1158\/1078-0432.CCR-04-1923","volume":"11","author":"KD Miller","year":"2005","unstructured":"Miller KD, Trigo JM, Wheeler C, Barge A, Rowbottom J, Sledge G, Baselga J (2005) A multicenter phase II trial of ZD6474, a vascular endothelial growth factor receptor-2 and epidermal growth factor receptor tyrosine kinase inhibitor, in patients with previously treated metastatic breast cancer. Clin Cancer Res 11(9):3369\u20133376","journal-title":"Clin Cancer Res"},{"issue":"3","key":"6937_CR59","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1007\/s10549-012-2285-0","volume":"136","author":"DA Yardley","year":"2012","unstructured":"Yardley DA, Dees EC, Myers SD, Li S, Healey P, Wang Z, Brickman MJ, Paolini J, Kern KA, Citrin DL (2012) Phase II open-label study of sunitinib in patients with advanced breast cancer. Breast Cancer Res Treat 136(3):759\u2013767","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"6937_CR60","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s10549-012-2256-5","volume":"136","author":"EL Mayer","year":"2012","unstructured":"Mayer EL, Isakoff SJ, Klement G, Downing SR, Chen WY, Hannagan K, Gelman R, Winer EP, Burstein HJ (2012) Combination antiangiogenic therapy in advanced breast cancer: a phase 1 trial of vandetanib, a VEGFR inhibitor, and metronomic chemotherapy, with correlative platelet proteomics. Breast Cancer Res Treat 136(1):169\u2013178","journal-title":"Breast Cancer Res Treat"},{"issue":"2","key":"6937_CR61","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1007\/s10637-010-9538-8","volume":"30","author":"K Bo\u00e9r","year":"2012","unstructured":"Bo\u00e9r K, L\u00e1ng I, Llombart-Cussac A, Andreasson I, Vivanco GL, Sanders N, Pover GM, Murray E (2012) Vandetanib with docetaxel as second-line treatment for advanced breast cancer: a double-blind, placebo-controlled, randomized Phase II study. Invest New Drugs 30(2):681\u2013687","journal-title":"Invest New Drugs"},{"issue":"4","key":"6937_CR62","first-page":"277","volume":"45","author":"X Matias-Guiu","year":"1988","unstructured":"Matias-Guiu X, Calabuig R, Badia F, Serra J, La Calle JP (1988) Spontaneous infarcts in fibroadenomas of the breast. Curr Surg 45(4):277\u2013279","journal-title":"Curr Surg"},{"issue":"11","key":"6937_CR63","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1158\/1078-0432.CCR-21-4179","volume":"28","author":"JSJ Lim","year":"2022","unstructured":"Lim JSJ, Wong ALA, Ow SGW, Ngoi NYL, Chan GHJ, Ang YLE, Chong WQ, Lim SE, Lim YW, Lee M, Choo JRE, Tan HL, Yong WP, Soo RA, Tan DSP, Chee CE, Sundar R, Yadav K, Jain S, Wang L, Tai BC, Goh BC, Lee SC (2022) Phase Ib\/II dose expansion study of lenvatinib combined with letrozole in postmenopausal women with hormone receptor-positive breast cancer. Clin Cancer Res 28(11):2248\u20132256","journal-title":"Clin Cancer Res"},{"issue":"1","key":"6937_CR64","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1186\/s12943-017-0727-3","volume":"16","author":"P W-xin","year":"2017","unstructured":"W-xin P, J-guo H, Yang L, A-hua G, Mo YY (2017) Linc-RoR promotes MAPK\/ERK signaling and confers estrogen-independent growth of breast cancer. Mol Cancer 16(1):161","journal-title":"Mol Cancer"},{"issue":"1","key":"6937_CR65","doi-asserted-by":"crossref","first-page":"e1010563","DOI":"10.1371\/journal.pgen.1010563","volume":"19","author":"L Ferrando","year":"2023","unstructured":"Ferrando L, Vingiani A, Garuti A, Vernieri C, Belfiore A, Agnelli L, Dagrada G, Ivanoiu D, Bonizzi G, Munzone E, Lippolis L, Dameri M, Ravera F, Colleoni M, Viale G, Magnani L, Ballestrero A, Zoppoli G, Pruneri G (2023) ESR1 gene amplification and MAP3K mutations are selected during adjuvant endocrine therapies in relapsing Hormone Receptor-positive, HER2-negative breast cancer (HR+ HER2- BC). PLoS Genet 19(1):e1010563","journal-title":"PLoS Genet"},{"issue":"9","key":"6937_CR66","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1097\/COC.0000000000000845","volume":"44","author":"PM Spanheimer","year":"2021","unstructured":"Spanheimer PM, Bashir A, Lorenzen AW, Beck AC, Liao J, Lizarraga IM, Erdahl LM, Sugg SL, Karwal MW, Weigel RJ (2021) A pilot study of preoperative vandetanib on markers of proliferation and apoptosis in breast cancer. Am J Clin Oncol 44(9):456\u2013462","journal-title":"Am J Clin Oncol"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-023-06937-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10549-023-06937-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-023-06937-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,12]],"date-time":"2023-05-12T04:08:42Z","timestamp":1683864522000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10549-023-06937-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,15]]},"references-count":66,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["6937"],"URL":"https:\/\/doi.org\/10.1007\/s10549-023-06937-9","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,15]]},"assertion":[{"value":"16 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no potential conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}